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Summary
Few choices exist for a mobile, rapid, and
nonsubjective assessment of mastitic infection in
bovine milk.  This project evaluated the
effectiveness of using the Biotrace® raw milk
quality ATP bioluminescence assay to serve this
role.  Milk samples with various somatic cell
counts (13,000 - 2,500,000) and signs of
mastitic infection were obtained from the
Kansas State University Dairy Teaching and
Research Center.  Within 24 hr, raw milk
samples were evaluated for microbial numbers
and relative light units (RLU).  The printed test
procedure was modified to evaluate accurately
clinical mastitic milk samples.  As somatic cell
count increased in raw milk, the RLU value
increased.  In addition, RLU values
differentiated among milk samples with various
levels of mastitic infection (none, subclinical, and
clinical). Repeatability of the ATP bio-lumine-
scence method was very good (CV = 4.76%).
These results suggest that the Biotrace® raw
milk quality test kit can served effectively as a
nonsubjective, rapid assay to determine the
degree of mastitic infection in bovine milk.
(Key Words: Mastitis, Somatic Cell Count,
ATP  Bioluminescence.)
Introduction
Problems with raw milk quality and
mammary gland health are among the most
costly health concerns on dairy farms.  Poor
mammary gland health adversely affects a
dairy's profitability in two distinct areas.  First,
milk price premiums and deductions are
determined in part by milk quality as indicated
by somatic cell count (SCC).  Secondly, a
lactating cow with a mastitis problem (SCC >
300,000) can show in a 10 to 15% reduction in
milk production compared to herd mates
without a mastitis problem.
Mastitis is an inflammation of the mammary
gland and can be caused by physical trauma or
more commonly by microbial infestation of the
mammary gland.  There are two categories of
mastitis: subclinical and clinical.  Cows with
subclinical mastitis produce milk without
physical abnormalities apparent to the naked
eye.  Subclinical mastitis accounts for 90 to
95% of all mastitis cases.  Cows with clinical
mastitis produce milk with obvious physical
abnormalities, namely, the presence of scar
tissue.
To combat the inflammation, the animal’s
immune system floods the affected area with
white blood cells or leukocytes (which make up
the majority of the cells in an SCC).  As a
result, the leukocyte concentration in the milk
increases.  The degree of inflammation is
directly proportional to the leukocyte
concentration.  This relationship allows the
health status of a lactating mammary gland to be
determined by enumerating somatic cells in the
milk.  Unfortunately, nonsubjective rapid
assessment of milk SCCs requires the use of
large, nonmobile, computer-driven equipment.
The physical environment inside the
mammary gland serves as an ideal growth
medium for a host of microorganisms, allowing
them to flourish and resulting in the immune
response previously described.  This rapid
microbial growth was confirmed recently;
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bacteria had an increased multiplication rate in
mastitic milk.  Increases in microbial adenosine
triphosphate (ATP) seem to correlate well with
indicators for mastitis inflammation.  The fact
that the most common cause of mastitis is
microbial infestation of the mammary gland
presents the opportunity to evaluate mammary
gland health by rapid microbial enumeration
procedures, such as ATP bioluminescence. 
Our objectives were to determine whether:
1) the Biotrace™ raw milk quality test kit
procedure was correlated with raw milk SCC
and 2) the Biotrace™ raw milk quality test kit
procedure could distinguish among raw bovine
milk samples with various degrees of mastitic
infection.
Procedures
Milk samples were collected from the
complete milking of each cow, stored at 2.8EC,
and assayed within 24 hr after collection.  With
each milk sample, triplicate microbial ATP
assays were performed, and duplicate SCC
values were obtained.
The Somacount 500 Analyzer (Bently
Industries Inc.) at the Heart of America DHIA
Lab, Manhattan, KS, was used to perform the
SCC assays.  Microbial ATP concentration
values were monitored using the Biotrace Multi-
Lite Milk Bacterial Kit (Biotrace, Bregend,
Wales).  1000µL of prewarmed (37EC)
Somex-A was added to 1 mL of raw milk,
rotamixed  for 5 seconds, incubated in a water
bath at 37EC for 4 minutes, and then rotamixed
again for 5 seconds.  Samples were filtered
through  a 13 mm sterile filter. The filter was
rinsed with 5mL of sterile rinse solution.  The
filter containing the microorganisms then was
removed with sterile forceps and placed
horizontally into a vial containing 500FL of the
microbial ATP extracting enzyme M-Bactex.
Contents of the vial were gently  mixed and
allowed to stand for 1 minute. Then 200 FL of
the solution was placed into a sterile cuvette, to
which 100 FL of the luciferin/luciferase reagent
(Enzyme-MLX) was added.
The ATP bioluminescence assay employs
an enzymatic reaction between luciferase and
microbial ATP.  The light emitted via the
luciferase reaction is measured by a Biotrace
Uni-Lite luminometer and quantified as relative
light units (RLU).  The RLU values then can be
related to the microbial population of the
sample.  In order to assay strictly microbial
ATP, somatic cell ATP and native milk ATP are
removed.  Somatic cells are less resistant to
physical stress elicited by the Biotrace
extractant Somex-A that causes the somatic
cells to rupture.  The somatic cell ATP and
native milk ATP then are flushed away from the
intact microbial cells in a filtration step.  The
extractant and filtration steps finalize the
selective removal of all nonmicrobial cells.
Five milk samples (labeled 1 through 5)
were prepared from raw milk samples collected
from three different cows, each with different
mammary health status.  These cows were
designated 1, 3, and 5.  Cow #1 (n = 4)
produced milk that showed no physical signs of
clinical mastitis and consistently maintained a
low SCC (<50,000).  This sample represented
milk from a healthy mammary gland.  Cow #3
(n = 4) produced milk that showed no physical
signs of clinical mastitis and consistently
maintained SCCs of >300,000 and
<1,000,000.   This sample represented milk
from a cow with subclinical mastitis.  Cow #5 (n
= 3) produced milk that showed physical signs
of clinical mastitis (scar tissue in the milk) and
consistently maintained SCCs >2,000,000.
This sample represented milk from a cow with
clinical mastitis.  Sample #2 (n = 4) was
prepared by a 50:50 volumetric mixture of milk
samples from cows #1 and #3.  This sample
represented milk produced by a cow with mild
subclinical mastitis relative to #3.  Sample #4 (n
= 3) was prepared by a 50:50 volumetric
mixture of milk samples from cows #1 and #5.
This sample represented milk produced by a
cow with mild clinical mastitis relative to #5.
Experiments were replicated five times.  All
data were transformed into log10 values before
statistical analyses were compared.  To
determine if SCCs differed among the different
milk treatments, SCCs were subjected to
analysis of variance.
Results and Discussion
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Figure 1 shows the strong correlation (r2 =
.95; P<.05) among the five milk treatments and
the SCCs.  This assay proved to be highly
repeatable across all data points (CV = 4%).
Thus, the Somacount 500 SCC assay served as
a standard for our investigation.
Figure 2 represents the relationship between
the five milk treatments and the ATP assay
results (expressed as log RLU).   A strong
correlation (r2= .90; P<.05) existed between
theATP assay and the samples with various
levels of mastitic infection.  The ATP assay also
exhibited high repeatability (CV = 4.8%).
Average values for the SCC assay and the
ATP assay are shown in Tables 1 and 2,
respectively.  Both assays exhibited similar
abilities to distinguish among clinical mastitis
(treatment 4 and 5), subclinical mastitis
(treatments 2 and 3), and no mastitic infection
(treatment 1).  The original milk samples
(treatments 1, 3, and 5) were distinguished
easily from each other.  However, we found that
both assays lack the ability to statistically
differentiate between mild clinical (treatment 4)
and clinical (treatment 5) mastitis and between
mild subclinical (treatment 2) and subclinical
(treatment 3) milk samples.  Our results indicate
that both assays were equally capable of
repeatedly distinguishing among various degrees
of mastitic infection.
As a final test, the Pearson correlation
coefficient was calculated for the dependent
variables, SCC and ATP value.  The
relationship between the two variables is
represented
in Figure 3 by a scatter plot of all RLU and
SCC data points.  A strong correlation
(Pearson correlation = .91; P = .001) existed
between the microbial load of the milk samples
(determined by the ATP assay) and the SCCs.
Conclusion
Statistical analyses of the results obtained
during this investigation illustrated the high
repeatability of the ATP assay and the high
degree of correlation between milk treatments
and ATP assay values.  Further analysis showed
a strong correlation between the ATP and SCC
values. The ATP assay also demonstrated the
ability to differentiate among milk samples with
various levels of mastitic infection:  none,
subclinical, and clinical.  These results suggest
that the Biotrace ATP assay could serve as a
highly repeatable and mobile alternative to the
SCC assay in monitoring bovine mastitic
infection.  Use of the Biotrace ATP for rapid,
on-the-farm, quantitative analyses of mastitic
infection deserves further investigation.
Figure 1.  Scatter Plot of Somatic Cell
Count (SCC) Values and Milk Treatments
(r2 = .95; P<.05; CV = 4%).
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Figure 2.  Scatter Plot of Microbial
ATP(RLU) Values and Five Milk
Treatments (R2 = .90; P<.05; CV = 4.8%).
Figure 3.  Scatter Plot of Microbial ATP
(RLU) and Somatic Cell Count (SCC)
Values from All Treatments (r = .91; P =
.001).
Table 1. Mean Relative Light Unit (RLU) Values from ATP Bioluminescence
Assay
Treatment Mastitis No. RLU
1 None 3 4.0a
2 Mild subclinical 3 3.9ab
3 Subclinical 4 3.6bc
4 Mild clinical 4 3.5c
5 Clinical 4 2.8d
a,b,c,dRLU values with uncommon superscript letters differ (P<.05).
Table 2. Mean Somatic Cell Counts
Treatment Mastitis No. Log SCC
1 None 3 6.4a
2 Mild subclinical 3 6.1ab
3 Subclinical 4 6.0bc
4 Mild clinical 4 5.7c
5 Clinical 4 4.1d
a,b,c,dLog SCC values with uncommon superscript letters differ (P<.05).
